Email updates

Keep up to date with the latest news and content from BMC Neurology and BioMed Central.

Open Access Highly Accessed Research article

Prevalence of celiac disease in multiple sclerosis

Luis Rodrigo1*, Carlos Hernández-Lahoz2, Dolores Fuentes1, Noemí Alvarez1, Antonio López-Vázquez3 and Segundo González3

Author affiliations

1 Gastroenterology, Hospital Universitario Central de Asturias (HUCA), c/Celestino Villamil, s. n°., 33006. Oviedo, Spain

2 Neurology, Hospital Universitario Central de Asturias (HUCA), c/Celestino Villamil, s. n°., 33006. Oviedo, Spain

3 Immunology Services Hospital Universitario Central de Asturias (HUCA), c/Celestino Villamil, s. n°., 33006. Oviedo, Spain

For all author emails, please log on.

Citation and License

BMC Neurology 2011, 11:31  doi:10.1186/1471-2377-11-31

Published: 7 March 2011

Abstract

Background

Celiac disease (CD) is a common systemic disease related to a permanent intolerance to gluten and is often associated with different autoimmune and neurological diseases. Its mean prevalence in the general population is 1-2% worldwide. Our aim was to study the prevalence of celiac disease in a prospective series of Multiple Sclerosis (MS) patients and their first-degree relatives.

Methods

We analyzed the prevalence of serological, histological and genetic CD markers in a series of 72 MS patients and in their 126 first-degree relatives, compared to 123 healthy controls.

Results

Tissue IgA-anti-transglutaminase-2 antibodies were positive in 7 MS patients (10%), compared to 3 healthy controls (2.4%) (p < 0.05). OR: 5.33 (CI-95%: 1.074-26.425). No differences were found in HLA-DQ2 markers between MS patients (29%) and controls (26%) (NS).

We detected mild or moderate villous atrophy (Marsh III type) in duodenal biopsies, in 8 MS patients (11.1%). We also found a high proportion of CD among first-degree relatives: 23/126 (32%). Several associated diseases were detected, mainly dermatitis 41 (57%) and iron deficiency anemia in 28 (39%) MS patients. We also found in them, an increased frequency of circulating auto-antibodies such as anti-TPO in 19 (26%), ANA in 11 (15%) and AMA in 2 (3%).

Conclusions

We have found an increased prevalence of CD in 8 of the 72 MS patients (11.1%) and also in their first-degree relatives (23/126 [32%]). Therefore, increased efforts aimed at the early detection and dietary treatment of CD, among antibody-positive MS patients, are advisable.